These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11900154)

  • 1. Illegal drug use and public policy.
    Grossman M; Chaloupka FJ; Shim K
    Health Aff (Millwood); 2002; 21(2):134-45. PubMed ID: 11900154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coke and smack at the drugstore: harm reductive drug legalization: an alternative to a criminalization society.
    Mamber N
    Cornell J Law Public Policy; 2006; 15(3):619-64. PubMed ID: 17593583
    [No Abstract]   [Full Text] [Related]  

  • 3. The long and winding road to cannabis legalization.
    Van Ours JC
    Addiction; 2012 May; 107(5):872-3. PubMed ID: 22471565
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of macro-level interventions on addictive behavior.
    Pacula RL; Chaloupka FJ
    Subst Use Misuse; 2001 Dec; 36(13):1901-22. PubMed ID: 11795584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual behaviours and substance use: the role of price.
    Grossman M
    Adv Health Econ Health Serv Res; 2005; 16():15-39. PubMed ID: 17867233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19.
    Caulkins JP; Kilmer B; MacCoun RJ; Pacula RL; Reuter P
    Addiction; 2012 May; 107(5):865-71. PubMed ID: 21985069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legalizing drugs: lessons from (and about) economics.
    Warner KE
    Milbank Q; 1991; 69(4):641-61. PubMed ID: 1806805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic analysis of different cannabis decriminalization scenarios.
    Ogrodnik M; Kopp P; Bongaerts X; Tecco JM
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S309-14. PubMed ID: 26417786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shifting from an illegal-drug policy to a psychoactive substance policy.
    van der Linde F
    Soz Praventivmed; 2006; 51(3):128-9. PubMed ID: 17191533
    [No Abstract]   [Full Text] [Related]  

  • 10. A social cost perspective in the wake of the Portuguese strategy for the fight against drugs.
    Gonçalves R; Lourenço A; Silva SN
    Int J Drug Policy; 2015 Feb; 26(2):199-209. PubMed ID: 25265899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical experience with legalized cannabis.
    Gieringer D
    Addiction; 2012 May; 107(5):875-6. PubMed ID: 22471567
    [No Abstract]   [Full Text] [Related]  

  • 12. Diminishing returns and great potential: a comment on Pollack's & Reuter's review on tougher drug enforcement and prices.
    Caulkins JP
    Addiction; 2014 Dec; 109(12):1967-8. PubMed ID: 25384929
    [No Abstract]   [Full Text] [Related]  

  • 13. Does tougher enforcement make drugs more expensive?
    Pollack HA; Reuter P
    Addiction; 2014 Dec; 109(12):1959-66. PubMed ID: 24621331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of tobacco regulation.
    Gruber J
    Health Aff (Millwood); 2002; 21(2):146-62. PubMed ID: 11900155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional considerations.
    Nadelmann E; Gutwillig S; Davies J
    Addiction; 2012 May; 107(5):873-5. PubMed ID: 22471566
    [No Abstract]   [Full Text] [Related]  

  • 16. A quagmire for our time: the war on drugs.
    Schrag P
    J Public Health Policy; 2002; 23(3):286-98. PubMed ID: 12325286
    [No Abstract]   [Full Text] [Related]  

  • 17. The analysis of policy: understanding the process of policy development.
    Ryder D
    Addiction; 1996 Sep; 91(9):1265-70. PubMed ID: 8854357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some critical issues in cannabis policy reform.
    Uchtenhagen A
    Addiction; 2014 Mar; 109(3):356-8. PubMed ID: 24524316
    [No Abstract]   [Full Text] [Related]  

  • 19. Legalization of drugs of abuse and the pediatrician.
    Schwartz RH
    Am J Dis Child; 1991 Oct; 145(10):1153-8. PubMed ID: 1928008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining the goals of national drug policy: recommendations from a working group.
    Reuter P; Caulkins JP
    Am J Public Health; 1995 Aug; 85(8 Pt 1):1059-63. PubMed ID: 7625496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.